Evidence map›Paper›PMID 36132704›Full record

ArticleNanoscale advances2022

Magneto-mechanical destruction of cancer-associated fibroblasts using ultra-small iron oxide nanoparticles and low frequency rotating magnetic fields.

Sara Lopez, Nicolas Hallali, Yoann Lalatonne, Arnaud Hillion, Joana C Antunes, Nizar Serhan, Pascal Clerc, Daniel Fourmy, Laurence Motte, Julian Carrey and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sara LopezLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Nicolas HallaliLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Yoann LalatonneUniversité Sorbonne Paris Nord, Laboratory for Vascular Translational Science, LVTS, INSERM, UMR 1148 F-93000 Bobigny France laurence.motte@sorbonne-paris-nord.fr.ORCID https://orcid.org/0000-0003-2235-6561
Arnaud HillionLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Joana C AntunesUniversité Sorbonne Paris Nord, Laboratory for Vascular Translational Science, LVTS, INSERM, UMR 1148 F-93000 Bobigny France laurence.motte@sorbonne-paris-nord.fr.
Nizar SerhanLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Pascal ClercLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Daniel FourmyLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Laurence MotteUniversité Sorbonne Paris Nord, Laboratory for Vascular Translational Science, LVTS, INSERM, UMR 1148 F-93000 Bobigny France laurence.motte@sorbonne-paris-nord.fr.
Julian CarreyLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.
Véronique GigouxLaboratoire de Physique et Chimie des Nano-Objets (LPCNO), CNRS-UPS-INSA UMR5215 135 Avenue de Rangueil F-31077 Toulouse France julian.carrey@insa-toulouse.fr.ORCID https://orcid.org/0000-0003-1408-5335
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The destruction of cells using the mechanical activation of magnetic nanoparticles with low-frequency magnetic fields constitutes a recent and interesting approach in cancer therapy. Here, we showed that superparamagnetic iron oxide nanoparticles as small as 6 nm were able to induce the death of pancreatic cancer-associated fibroblasts, chosen as a model. An exhaustive screening of the amplitude, frequency, and type (alternating

Identifiers

PMID36132704
PMCPMC9417452
OpenAlexW3216998314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.